General Electric Company (NYSE:GE) | New Studies Show How Using GE Healthcare’s MultiOmyx™ in Hodgkin Lymphoma and Breast Cancer Cases May Improve Disease Assessment

[Business Wire] – GE Healthcare today announced results from two studies that show how using the MultiOmyx™ Hodgkin Lymphoma Profile and an investigational profile for breast cancer may improve Read more on this. . . . → Read More: General Electric Company (NYSE:GE) | New Studies Show How Using GE Healthcare’s MultiOmyx™ in Hodgkin Lymphoma and Breast Cancer Cases May Improve Disease Assessment Similar posts: Prudential Financial Inc. (NYSE:PRU) – Rebounds in equities and housing fail to substantially improve retirement security Stock Update: United Parcel Service Inc. (NYSE:UPS) – Elon Musk says Tesla may build electric pickup truck modeled after Ford F-150 Company Update: Morgan Stanley (NYSE:MS) – Moelis taps Morgan Stanley healthcare banker